4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000129
Chairperson & CEO sold 9,500 shares at an average $517.28 ($4,914,190)
- Chairperson & CEO acquired 9,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
ROTHBLATT MARTINE A · Chairperson & CEO
Table I: Non-derivative
9 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-08-26 | Exercise or conversion : show line 1 in the form 10b5-1 | +9,500 | $135.42 | $1,286,490 | 333,943 | I |
| 2026-08-26 | Sale : show line 2 in the form 10b5-1 | −559 | $514.64 | $287,682 | 333,384 | I |
| 2026-08-26 | Sale : show line 3 in the form 10b5-1 | −1,591 | $515.41 | $820,010 | 331,793 | I |
| 2026-08-26 | Sale : show line 4 in the form 10b5-1 | −1,128 | $516.70 | $582,832 | 330,665 | I |
| 2026-08-26 | Sale : show line 5 in the form 10b5-1 | −3,516 | $517.49 | $1,819,503 | 327,149 | I |
| 2026-08-26 | Sale : show line 6 in the form 10b5-1 | −1,790 | $518.35 | $927,846 | 325,359 | I |
| 2026-08-26 | Sale : show line 7 in the form 10b5-1 | −476 | $519.35 | $247,211 | 324,883 | I |
| 2026-08-26 | Sale : show line 8 in the form 10b5-1 | −400 | $520.62 | $208,247 | 324,483 | I |
| 2026-08-26 | Sale : show line 9 in the form 10b5-1 | −40 | $521.48 | $20,859 | 324,443 | I |
| Open-market sales · 9,500 sh · avg $517.28 · $4,914,190 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-08-26 | Exercise or conversion : show line 10 in the form 10b5-1 Stock Option | −9,500 | 56,410 | I |
Loading xslF345X06/primarydocument.xml…